Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers

Molecular Carcinogenesis

Volumn 42, Issue 3, 2005, Pages 150-158

  Takahashi, Yuji ^a   Kondo, Kazuya ^a   Hirose, Toshiyuki ^a   Nakagawa, Hidewaki ^b   Tsuyuguchi, Masaru ^c   Hashimoto, Masato ^d   Sano, Toshiaki ^a   Ochiai, Atsushi ^e   Monden, Yasumasa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OHIO STATE UNIVERSITY   (United States)

^c TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d Iwamizawa Rosai Hospital   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Carcinogenesis; Chromium; Gene instability; Methylation

Indexed keywords

CHROMIC ACID; DNA MISMATCH REPAIR PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE INACTIVATION; GENE LOCUS; GENE REPRESSION; HMLH1 GENE; HMSH2 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MICROSATELLITE INSTABILITY; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BASE PAIR MISMATCH; CARRIER PROTEINS; CHROMATES; DNA METHYLATION; DNA REPAIR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PROMOTER REGIONS (GENETICS);

EID: 13944261633     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20073     Document Type: Article

References (34)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, and the prevention of cancer: A global respective. Washington (DC): American Institute for Cancer Research, 1997.
2. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210.
3. International Agency for Research on Cancer (IARC). Chromium and certain chromium compounds. In: IARC editor. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon: IARC; 1982. pp 91-93.
4. Mikalsen A, Alexander J, Wallin H, Ingelman-Sundberg M, Andersen RA. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. Carcinogenesis 1991;12:825-831.
5. Tsuneta Y. Investigations of the pathogenesis of lung cancer observed among chromate factory workers (in Japanese). Hokkaido Igaku Zasshi 1982;57:175-187.
6. International Agency for Research on Cancer (IARC). Chromium, nickel, and welding. In: IARC editor. IARC monographs on the evaluation of carcinogenesis risk to humans. Lyon: IARC; 1990. pp 49-255.
7. Kondo K, Hino N, Sasa M, et al. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophys Res Commun 1997;239: 95-100.
8. Ewis AA, Kondo K, Lee J, et al. Occupational cancer genetics: Infrequent ras oncogenes point mutations in lung cancer samples from chromate workers. Am J Ind Med 2001;40: 92-97.
9. Hirose T, Kondo K, Takahashi Y, et al. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog 2002;33:172-180.
10. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996;111:307-317.
11. Losi L, Ponz de Leon M, Jiricny J, et al. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers. Int J Cancer 1997;74:94-96.
12. Peltomaki P. Deficient DNA mismatch repair: A common etiologic factor for colon cancer. Hum Mol Genet 2001;10: 735-740.
13. Union International Contre le Cancer (UICC), Sherman CC. Manual of clinical oncology. 4th edition. Berlin: Springer-Verlag; 1987.
14. World Health Organization. Histological typing of lung tumours. 2nd edition. Geneva: World Health Organization; 1981.
15. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22:2990-2997.
16. Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 1999;59:2029-2033.
17. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999;9:89-96.
18. Honchel R, Halling KC, Thibodeau SN. Genomic instability in neoplasia. Semin Cell Biol 1995;6:45-52.
19. Loeb LA. Many mutations in cancers. Cancer Surv 1996;28: 329-342.
20. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
21. Salvesen HB, MacDonald N, Ryan A, et al. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 2000;6:3607-3613.
22. Bevilacqua RA, Simpson AJ. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer 2000;87:200-203.
23. Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
24. Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomaki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 2000;156:1773-1779.
25. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-1718.
26. Nakagawa H, Nuovo GJ, Zervos EE, et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001;61:6991-6995.
27. Xiong Z, Laird PW. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-2534.
28. Chang JW, Chen YC, Chen CY, Chen JT, Chen SK, Wang YC. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer. Clin Cancer Res 2000;6:1639-1646.
29. Xinarianos G, Liloglou T, Prime W, et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 2000;60: 4216-4221.
30. Aubry MC, Hailing KC, Myers JL, Tazelaar HD, Yang P, Thibodeau SN. DNA mismatch repair genes hMLH1, hMSH2, and hMSH6 are not inactivated in bronchioloalveolar carcinomas of the lung. Cancer 2001;92:2898-2901.
31. Hartwig A. Carcinogenicity of metal compounds: Possible role of DNA repair inhibition. Toxicol Lett 1998;102:235-239.
32. Maeng SH, Chung HW, Yu IJ, et al. Changes of 8-OH-dG levels in DNA and its base excision repair activity in rat lungs after inhalation exposure to hexavalent chromium. Mutat Res 2003;539:109-116.
33. Hodges NJ, Chipman JK. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis 2002;23:55-60.
34. Asmuss M, Mullenders LHF, Eker A, Hartwig A. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis 2000;21:2097-2104.